The price cap
NHS England's VBP is business as usual: price ≤40%, value ≥60% — and no blanket maximum pricing thresholds.
Free field guide · PDF
Device Pricing & VBP2026 Field Guide
The price cap, the value shift, and the dossier logic — with the market-access practice you need.
- NHS VBP
- 60/40
- SAR/QALY
- 50–75k
- NUPCO gate
- MDMA
Sourced from verified 2026 publications.
Download the free guide
Enter your work email and we'll send the PDF straight to your inbox.
What's inside
Five pages, zero fluff
Every figure in this guide traces to a named source — verified 2026 publications.
The value shift
From 'what does it cost?' to 'what value does it create?' — the value-shift logic sweeping tenders worldwide.
The dossier logic
The NUPCO playbook: MDMA-first listing, reference pricing, SAR 50–75k/QALY, and the full pricing dossier.
Sources & scope
- openaccessgovernment.org, Value-Based Procurement in healthcare (2026).
- med-techinsights.com, Ministerial commitment on NHS value-based procurement (Sep 2026).
- meddeviceguide.com, Saudi Arabia NUPCO Medical Device Procurement and Market Entry Guide.
This guide is market-access intelligence, not pricing, reimbursement, or legal advice. Procurement rules, HTA thresholds, and payer policies change — professional review is required before business use.
Market Access Strategy Session
Pricing on your 2026 roadmap? Start with the full picture.
A Market Access Strategy Session maps your pricing route — tender strategy, value dossiers, and market-specific thresholds.
Professional review is required before business use.
Back to ghmap.io Questions? Talk to our team